Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
Over the last 12 months, insiders at Bullfrog AI Holdings, Inc. Common Stock have bought $0 and sold $0 worth of Bullfrog AI Holdings, Inc. Common Stock stock.
On average, over the past 5 years, insiders at Bullfrog AI Holdings, Inc. Common Stock have bought $20,250 and sold $471,680 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $20,250 was made by Enright William (director) on 2023‑06‑14.
2024-01-22 | Sale | Singh Vininder | Chief Executive Officer | 25,000 1.0009% | $7.50 | $187,500 | -60.21% | |
2024-01-17 | Sale | Singh Vininder | Chief Executive Officer | 4,848 0.0824% | $3.18 | $15,440 | -15.99% | |
2024-01-16 | Sale | Singh Vininder | Chief Executive Officer | 8,516 0.1161% | $2.55 | $21,741 | +1.70% | |
2024-01-12 | Sale | Singh Vininder | Chief Executive Officer | 1,515 0.0207% | $2.56 | $3,873 | +5.08% | |
2024-01-11 | Sale | Singh Vininder | Chief Executive Officer | 5,660 0.078% | $2.58 | $14,613 | +4.67% | |
2024-01-10 | Sale | Singh Vininder | Chief Executive Officer | 4,780 0.0702% | $2.75 | $13,156 | -2.18% | |
2024-01-09 | Sale | Singh Vininder | Chief Executive Officer | 3,144 0.0473% | $2.82 | $8,859 | -3.93% | |
2024-01-08 | Sale | Singh Vininder | Chief Executive Officer | 5,184 0.0797% | $2.88 | $14,925 | -6.75% | |
2024-01-05 | Sale | Singh Vininder | Chief Executive Officer | 2,644 0.0409% | $2.90 | $7,662 | -7.53% | |
2024-01-04 | Sale | Singh Vininder | Chief Executive Officer | 3,569 0.0534% | $2.80 | $10,001 | -4.26% | |
2024-01-03 | Sale | Singh Vininder | Chief Executive Officer | 5,676 0.0662% | $2.18 | $12,393 | -4.59% | |
2024-01-02 | Sale | Singh Vininder | Chief Executive Officer | 4,464 0.0749% | $3.14 | $14,030 | -10.00% | |
2023-09-05 | Sale | Singh Vininder | Chief Executive Officer | 50,000 0.7873% | $2.95 | $147,485 | -3.95% | |
2023-06-14 | Enright William | director | 5,000 0.1081% | $4.05 | $20,250 | +41.86% |
Increased Positions | 7 | +87.5% | 67,281 | +27.55% |
Decreased Positions | 2 | -25% | 11,117 | -4.55% |
New Positions | 4 | New | 53,766 | New |
Sold Out Positions | <1 | Sold Out | 10,317 | Sold Out |
Total Postitions | 13 | +62.5% | 300,393 | +23% |
Vanguard Group Inc | $218.00 | 1.38% | 124,147 | 0 | 0% | 2024-12-31 |
Fortem Financial Group, Llc | $89.00 | 0.56% | 50,600 | -800 | -1.56% | 2024-12-31 |
Geode Capital Management, Llc | $83.00 | 0.52% | 47,093 | +11,140 | +30.98% | 2024-12-31 |
Two Sigma Securities, Llc | $36.00 | 0.23% | 20,701 | +20,701 | New | 2024-12-31 |
Ubs Group Ag | $32.00 | 0.2% | 18,054 | +18,054 | New | 2024-12-31 |
Raymond James & Associates | $26.00 | 0.17% | 15,000 | 0 | 0% | 2024-09-30 |
Raymond James Financial Inc | $26.00 | 0.17% | 15,000 | +15,000 | New | 2024-12-31 |
Morgan Stanley | $11.00 | 0.07% | 6,476 | 0 | 0% | 2024-12-31 |
Tower Research Capital Llc (Trc) | $6.00 | 0.04% | 3,254 | +2,367 | +266.86% | 2024-12-31 |
Bank Of America Corp /De/ | $0 | 0% | 42 | +8 | +23.53% | 2024-12-31 |